- BNF:
- 8.1.5
- Status:
- Do Not Prescribe (DNP), Red
- Decision Date:
- September 2016
Comments
RED:
- NICE TA401: for previously treated chronic myeloid leukaemia. Is recommended within its marketing authorisation for treating Philadelphia-chromosome-positive chronic myeloid leukaemia. (NHSE commissioned). (Decision date - September 2016).
Do Not Prescribe (DNP):
- NICE TA576: for untreated chronic myeloid leukaemia. (Terminated appraisal). (Decision date - May 2019).
NHS England drug. To be used in line with NHSE commissioning intentions.
Do Not Prescribe (DNP) Drug Classifications
- 6: Have NICE guidance that recommends they should not be used
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again